Inventor · disambiguated record
Christopher Moyes
Also filed as: MOYES CHRISTOPHER · MOYES CHRISTOPHER R · MOYES CHRISTOPHER RICHARD
20 granted patents·12 pending applications·209 citations·filing 1996–2025
94Inventor score
Top patents by PatentIndex Score
32 records- 0196US11512065B2GPR119 agonistsKALLYOPE INC·Filed 2022·Granted Nov 29, 2022·7 cites·20 claims
- 0295US6479480B1Phenylindole derivatives as 5-ht2a receptor ligandsMERCK SHARP & DOHME·Filed 1999·Granted Nov 12, 2002·89 cites·8 claims
- 0392US8354403B2Pyrrolidine derived beta 3 adrenergic receptor agonistsMERCK SHARP & DOHME·Filed 2010·Granted Jan 15, 2013·15 cites·14 claims
- 0481US9884125B2Glucose-responsive insulin conjugatesMERCK SHARP & DOHME·Filed 2014·Granted Feb 6, 2018·3 cites·2 claims
- 0579US11041009B2Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetesMERCK SHARP & DOHME·Filed 2018·Granted Jun 22, 2021·2 cites·6 claims
- 0679US6608062B1Imidazo-triazine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2000·Granted Aug 19, 2003·12 cites·9 claims
- 0778US6812234B2Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityMERCK & CO INC·Filed 2003·Granted Nov 2, 2004·14 cites·29 claims
- 0875US7230008B2Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityMERCK & CO INC·Filed 2004·Granted Jun 12, 2007·5 cites·12 claims
- 0973US12281114B2NK3 modulators and uses thereofKALLYOPE INC·Filed 2024·Granted Apr 22, 2025·0 cites·20 claims
- 1072US7442701B2Amino-heterocycles as VR-1 antagonists for treating painMERCK SHARP & DOHME·Filed 2003·Granted Oct 28, 2008·6 cites·10 claims
- 1170US7786305B2Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityMERCK SHARP & DOHME·Filed 2004·Granted Aug 31, 2010·4 cites·5 claims
- 1270US6133255ATricyclic pyridone analogues as GABA-A receptor ligandsMERCK SHARP & DOHME·Filed 1998·Granted Oct 17, 2000·29 cites·7 claims
- 1366US2023061736A1Gpr119 agonistsKALLYOPE INC·Filed 2022·Application pending·0 cites
- 1463US6352994B2Substituted 1H-pyridinyl-2-ones as GABAA alpha 2/3 ligandsMERCK SHARP & DOHME·Filed 2001·Granted Mar 5, 2002·1 cites·8 claims
- 1562US6200982B1Substituted 1H-pyridinyl-2-ones as GABAA-α 2/3 ligandsMERCK SHARP & DOHME·Filed 1998·Granted Mar 13, 2001·16 cites·9 claims
- 1661US7285563B2Heteroaromatic urea derivatives as VR-1 receptor modulators for treating painBROWN REBECCA ELIZABETH·Filed 2003·Granted Oct 23, 2007·5 cites·12 claims
- 1761US7166614B2Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activityMERCK SHARP & DOHME·Filed 2003·Granted Jan 23, 2007·1 cites·27 claims
- 1861US2024424109A1Glucose-responsive insulin conjugates comprising a tetra-valent sugar cluster for treatment of diabetesMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1961US2023113609A1Sstr5 antagonistsKALLYOPE INC·Filed 2020·Application pending·0 cites
- 2058US2024217983A1Gpr119 agonistsKALLYOPE INC·Filed 2022·Application pending·0 cites
- 2157US2023310551A1Insulin receptor partial agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2256US2025263410A1Nk3 modulators and uses thereofKALLYOPE INC·Filed 2025·Application pending·0 cites
- 2351US2022273770A1Glucose-responsive insulin conjugatesFENG DANQING·Filed 2020·Application pending·0 cites
- 2448US7598243B2Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activityMERCK & CO INC·Filed 2004·Granted Oct 6, 2009·0 cites·11 claims
- 2545US2005197342A1Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating painFiled 2004·Application pending·0 cites
- 2644US2010069347A1Heterocyclyl-substituted anti-hypercholesterolemic compoundsMORRIELLO GREGORI J·Filed 2007·Application pending·0 cites
- 2740US9006228B2Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatmentMILLER MICHAEL·Filed 2012·Granted Apr 14, 2015·0 cites·19 claims
- 2840US2011152242A12,3-Substituted Fused Pyrimidin -4 (3H)-Ones as VR1 AntagonistsBAYLISS TRACY·Filed 2006·Application pending·0 cites
- 2939US2006030582A1Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activityDEMARTINO JULIE·Filed 2005·Application pending·0 cites
- 3035US2009012061A1A Method of Treating CancerBLIZZARD TIMOTHY A·Filed 2005·Application pending·0 cites
- 3133US8604038B2Pyrrolidine derived beta 3 adrenergic receptor agonistsEDMONDSON SCOTT D·Filed 2010·Granted Dec 10, 2013·0 cites·14 claims
- 3230US6048878ASubstituted piperidine derivatives as selective agonists of 5-HT receptorsMERCK SHARP & DOHME·Filed 1996·Granted Apr 11, 2000·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Christopher Moyes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →